Key Takeaways Chronic, low-grade inflammation and insulin resistance drive each other in a two-way loop that starts largely in visceral fat. Mesenchymal stem cells are being studied for their ability to calm this inflammation and support insulin sensitivity, not to replace diet, exercise, or medication. A 2022 randomized trial found
Key Takeaways Stem cell treatment for congestive heart failure targets the weak heart muscle directly, rather than just managing symptoms. Mesenchymal stem cells MSCs release growth factors that support cardiac repair, reduce inflammation, and may promote the growth of new blood vessels in the heart. Clinical trials and clinical studies
Quick Summary In 2026, stem cell therapy for diabetes shows measurable improvement in 60-80% of patients, including better blood sugar control, reduced insulin use, and improved insulin resistance. Type 2 diabetes patients often respond better than type 1. However, full remission remains uncommon, and results depend on disease duration, treatment
Quick Read Summary Research Findings Clinical trials show that mesenchymal stem cells, kidney stem cells, and stem cell derived therapies may support kidney repair. Early results indicate slower progression of CKD, reduced inflammation, and improved kidney function. Results vary depending on stem cell type, dosage, and delivery method. Key Points
Quick Read Summary Stem Cell Therapy For Diabetes Type 2: Can It Help Blood Sugar Control? Stem cell therapy is being studied as a potential way to improve insulin production and support blood sugar control in diabetes type 2. Early clinical trial results show some patients had lower blood sugar
